Evotec Se (EVO)
4.24 +0.02 (+0.47%) 12:26 ET [NASDAQ]
4.22 x 11 4.25 x 2
Realtime by (Cboe BZX)
4.22 x 11 4.25 x 2
Realtime 4.25 +0.03 (+0.71%) 09:28 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | EVO | SPRY | ARDX | ||
| Company | Evotec Se | Ars Pharmaceuticals Inc | Ardelyx Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.23 | 13.89 | 5.30 | ||
| High | 4.25 | 14.27 | 5.39 | ||
| Low | 4.21 | 13.83 | 5.29 | ||
| Last | 4.24 | 14.04 | 5.32 | ||
| Change | +0.02 | +0.27 | +0.06 | ||
| % Change | +0.36% | +1.96% | +1.14% | ||
| Volume | 24,723 | 415,983 | 1,584,524 | ||
| 20-Day Average Volume | 93,490 | 1,734,064 | 5,288,463 | ||
| Previous Close | 4.22 | 13.77 | 5.26 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.48 | 13.77 | 4.71 | ||
| 20-Day Raw Stochastic | 98.58% | 57.80% | 93.80% | ||
| 20-Day Relative Strength | 63.46% | 53.91% | 56.06% | ||
| Weighted Alpha | -10.47 | +34.03 | -25.07 | ||
| Today's Opinion | 8% Buy | 56% Buy | 40% Sell | ||
| Previous Opinion | 8% Buy | 56% Buy | 48% Sell | ||
| Last Month's Opinion | 72% Sell | 16% Sell | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.16% since 04/21/25 | -2.90% since 04/21/25 | +16.34% since 04/21/25 | ||
| Low | 3.77 on 04/22/25 | 13.66 on 04/25/25 | 4.57 on 04/22/25 | ||
| High | 4.25 on 04/28/25 | 15.44 on 04/23/25 | 5.39 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +27.79% since 03/28/25 | +11.32% since 03/28/25 | +7.61% since 03/28/25 | ||
| Low | 2.84 on 04/07/25 | 11.80 on 04/09/25 | 4.02 on 04/09/25 | ||
| High | 4.25 on 04/28/25 | 15.44 on 04/23/25 | 5.39 on 04/28/25 | ||
| 3-Month | |||||
| %Chg | +0.71% since 01/28/25 | -6.56% since 01/28/25 | -3.37% since 01/28/25 | ||
| Low | 2.84 on 04/07/25 | 10.00 on 03/04/25 | 4.02 on 04/09/25 | ||
| High | 4.76 on 02/06/25 | 15.44 on 04/23/25 | 6.55 on 02/19/25 | ||
| 6-Month | |||||
| %Chg | +9.59% since 10/28/24 | -7.24% since 10/28/24 | -10.08% since 10/28/24 | ||
| Low | 2.84 on 04/07/25 | 10.00 on 03/04/25 | 4.02 on 04/09/25 | ||
| High | 5.64 on 11/15/24 | 18.51 on 11/11/24 | 6.55 on 02/19/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,086,627 | 1,255,936 | 1,084,520 | ||
| Shares Outstanding, K | 355,107 | 98,120 | 238,356 | ||
| Annual Sales | 845,740,000 | 89,150,000 | 333,620,000 | ||
| Annual Net Income | -90,820,000 | 8,000,000 | -39,140,000 | ||
| Last Quarter Sales | 203,310,000 | 86,580,000 | 116,130,000 | ||
| Last Quarter Net Income | -43,580,000 | 49,930,000 | 4,640,000 | ||
| 60-Month Beta | 1.69 | 0.86 | 0.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.52 on 03/20/25 | 0.02 on 02/20/25 | ||
| Latest Earnings Date | 11/06/24 | 05/08/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 172.13 | 0.00 | ||